MBX Biosciences (MBX) Shares Outstanding (2023 - 2026)

MBX Biosciences has reported Shares Outstanding (Entity) for 4 years, with the latest figure at $47.6 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 42.32% year-over-year to $47.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $47.6 million (up 42.32% YoY) and the FY2025 annual result came in at $36.5 million, up 243.01% from the prior year.
• Shares Outstanding (Entity) rose to $47.6 million in Q1 2026 per MBX's latest filing, from $36.5 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $47.6 million in Q1 2026 and troughed at $1.0 million in Q4 2023.
• A 4-year average of $18.8 million and a median of $10.6 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Entity) soared 2485.03% in 2025, then soared 42.32% in 2026.
• Over 4 years, Shares Outstanding (Entity) stood at $1.0 million in 2023, then surged by 944.7% to $10.6 million in 2024, then soared by 243.01% to $36.5 million in 2025, then surged by 30.31% to $47.6 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $47.6 million, $36.5 million, and $34.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.